Research-based PAM50 signature and long-term breast cancer survival

被引：0
|
作者：
Minya Pu
Karen Messer
Sherri R. Davies
Tammi L. Vickery
Emily Pittman
Barbara A. Parker
Matthew J. Ellis
Shirley W. Flatt
Catherine R. Marinac
Sandahl H. Nelson
Elaine R. Mardis
John P. Pierce
Loki Natarajan
机构：
[1] University of California,Moores Cancer Center
[2] San Diego,Department of Family Medicine and Public Health
[3] University of California,Department of Medicine
[4] San Diego,Department of Medicine
[5] Washington University St. Louis,Baylor College of Medicine
[6] Washington University St. Louis,Division of Population Sciences, Department of Medical Oncology
[7] McDonnell Genome Institute,Department of Epidemiology
[8] University of California,undefined
[9] San Diego,undefined
[10] Lester and Sue Smith Breast Center,undefined
[11] Nationwide Children’s Hospital,undefined
[12] Institute for Genomic Medicine,undefined
[13] Dana-Farber Cancer Institute,undefined
[14] Harvard T.H. Chan School of Public Health,undefined
[15] Precision for Medicine,undefined
来源：
Breast Cancer Research and Treatment | 2020年 / 179卷
关键词：
Breast cancer; Long-term survival; Gene signatures; Hypoxia; PAM50 subtypes; Prognostic modeling;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：197 / 206
页数：9
相关论文
共 50 条
  • [41] Metastatic breast cancer, long-term survival
    Navarro, F
    Villanueva, MJ
    Provencio, M
    Sánchez, A
    Cubedo, R
    Bonilla, F
    España, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S51 - S51
  • [42] PAM50 breast cancer subtypes and survival of patients in rural Ethiopia without adjuvant treatment: a prospective observational study
    Balle, Judith Katharina
    Vetter, Martina
    Kenea, Tariku Wakuma
    Eber-Schulz, Pia
    Reibold, Christian
    Ziegenhorn, Hannes-Viktor
    Stueckrath, Kathrin
    Wickenhauser, Claudia
    Addissie, Adamu
    Santos, Pablo
    Kantelhardt, Eva Johanna
    Getachew, Sefonias
    Bauer, Marcus
    BMC CANCER, 2024, 24 (01)
  • [43] Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes
    Santonja, Angela
    Sanchez-Munoz, Alfonso
    Fernandez, Yessica Plata
    Miramon, Jose
    Zarcos, Irene
    Perez, Casilda Llacer
    de Luque, Vanessa
    Fernandez-Sousa, Cristina
    Jerez, Jose Manuel
    Alvarez, Martina
    Vicioso, Luis
    Alba, Emilio
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer
    Ohara, Ako Matsushita
    Naoi, Yasuto
    Shimazu, Kenzo
    Kagara, Naofumi
    Shimoda, Masafumi
    Tanei, Tomonori
    Miyake, Tomohiro
    Kim, Seung Jin
    Noguchi, Shinzaburo
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 173 (03) : 533 - 543
  • [45] PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer
    Ako Matsushita Ohara
    Yasuto Naoi
    Kenzo Shimazu
    Naofumi Kagara
    Masafumi Shimoda
    Tomonori Tanei
    Tomohiro Miyake
    Seung Jin Kim
    Shinzaburo Noguchi
    Breast Cancer Research and Treatment, 2019, 173 : 533 - 543
  • [46] Race and age differences in PAM50 biomarker status in the Carolina breast cancer study
    Troester, M. A.
    Sun, X.
    Allott, E. H.
    Kit, C-K
    Thorne, L.
    Mathews, M.
    Cohen, S. M.
    Geradts, J.
    Kirk, E.
    Li, Y.
    Hu, Z.
    Robinson, W.
    Hoadley, K. A.
    Reeder-Hayes, K.
    Earp, S.
    Olshan, A. F.
    Carey, L. A.
    Perou, C. M.
    CANCER RESEARCH, 2017, 77
  • [47] Association between PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients
    Jorgensen, C. L. T.
    Nielsen, T. O.
    Bjerre, K. D.
    Liu, S.
    Wallden, B.
    Balslev, E.
    Nielsen, D. L.
    Ejlertsen, B.
    CANCER RESEARCH, 2012, 72
  • [48] Race and breast cancer prognosis by PAM50 subtype in the LACE and Pathways studies.
    Kroenke, Candvce
    Kwan, Marilyn
    Bernard, Philip
    Castillo, Adrienne
    Davis, Carole
    Factor, Rachel
    Habel, Laurel
    Kushi, Larry
    Quesenberry, Charles
    Shakespear, Kaylynn
    Stijleman, Inge
    Sweeney, Carol
    Weltzien, Erin
    Caan, Bette
    CANCER RESEARCH, 2013, 73 (08)
  • [49] Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression
    Kwan, Marilyn L.
    Kroenke, Candyce H.
    Sweeney, Carol
    Bernard, Philip S.
    Weltzien, Erin
    Castillo, Adrienne
    Factor, Rachel E.
    Shakespear, Kaylynn
    Stijleman, Inga J.
    Quesenberry, Charles P.
    Habel, Laurel A.
    Kushi, Lawrence H.
    Caan, Bette J.
    CANCER RESEARCH, 2014, 74 (19)
  • [50] Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression
    Kwan, Marilyn L.
    Kroenke, Candyce H.
    Sweeney, Carol
    Bernard, Philip S.
    Weltzien, Erin K.
    Castillo, Adrienne
    Factor, Rachel E.
    Maxfield, Kaylynn S.
    Stijleman, Inge J.
    Kushi, Lawrence H.
    Quesenberry, Charles P., Jr.
    Habel, Laurel A.
    Caan, Bette J.
    BMC CANCER, 2015, 15
12345